• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考虑雌激素和孕激素受体状态的Ⅰ级和Ⅱ级子宫内膜腺癌的超微结构比较

An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor status.

作者信息

Horbelt D V, Freedman R S, Roberts D K, Walker N J, Edwards C L, Jones L A

出版信息

Gynecol Oncol. 1984 Jun;18(2):150-6. doi: 10.1016/0090-8258(84)90022-2.

DOI:10.1016/0090-8258(84)90022-2
PMID:6735260
Abstract

Eighteen (18) previously untreated patients with grade I (9) and II (9) endometrial adenocarcinoma provided endometrial samples for biochemical analysis of estrogen and progesterone receptors. The same samples were evaluated by histology and ultrastructure. Progesterone receptor negative samples (PR less than 1000 fmole/g tissue) showed more ultrastructural characteristics of malignancy and a wider range of changes than the progesterone positive specimens (PR greater than 1000 fmole/g tissue). These findings appeared to be independent of estrogen receptor status. No significant ultrastructural changes were seen when grades I and II were compared.

摘要

18例先前未经治疗的I级(9例)和II级(9例)子宫内膜腺癌患者提供了子宫内膜样本,用于雌激素和孕激素受体的生化分析。对相同样本进行了组织学和超微结构评估。与孕激素受体阳性标本(PR大于1000飞摩尔/克组织)相比,孕激素受体阴性样本(PR小于1000飞摩尔/克组织)显示出更多的恶性超微结构特征和更广泛的变化范围。这些发现似乎与雌激素受体状态无关。比较I级和II级时,未观察到明显的超微结构变化。

相似文献

1
An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor status.考虑雌激素和孕激素受体状态的Ⅰ级和Ⅱ级子宫内膜腺癌的超微结构比较
Gynecol Oncol. 1984 Jun;18(2):150-6. doi: 10.1016/0090-8258(84)90022-2.
2
Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
Cancer. 1986 Oct 1;58(7):1506-17. doi: 10.1002/1097-0142(19861001)58:7<1506::aid-cncr2820580722>3.0.co;2-6.
3
Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.子宫内膜腺癌患者的类固醇受体与临床结局
Am J Obstet Gynecol. 1988 Apr;158(4):796-807. doi: 10.1016/0002-9378(88)90075-0.
4
Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.子宫内膜腺癌中雌激素和孕激素受体与组织学分化的相关性
Am J Pathol. 1979 Jul;96(1):171-83.
5
Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.正常、增生性及癌性子宫内膜中的细胞质孕酮和雌二醇受体:治疗意义
Am J Obstet Gynecol. 1981 Nov 1;141(5):539-46. doi: 10.1016/s0002-9378(15)33275-0.
6
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.子宫内膜癌中的雌激素和孕激素受体及其预后相关性。
Gynecol Oncol. 1990 Jul;38(1):59-65. doi: 10.1016/0090-8258(90)90012-a.
7
Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
Obstet Gynecol. 1986 Apr;67(4):463-7.
8
Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
Am J Obstet Gynecol. 1985 Apr 1;151(7):922-32. doi: 10.1016/0002-9378(85)90671-4.
9
Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
Obstet Gynecol. 1980 Mar;55(3):363-70. doi: 10.1097/00006250-198003000-00019.
10
[Endometrial cancer in the light of the studies of the estrogen and progesterone receptors in the cytosol].基于胞质溶胶中雌激素和孕激素受体研究的子宫内膜癌
Ginekol Pol. 1982;53(9):599-603.